0
Skip to Content
Nome
Why We Care
The Team
For Rare Disease Clinicians
FAQs
Protecting Your Data
News
Blog
Get Started
Nome
Why We Care
The Team
For Rare Disease Clinicians
FAQs
Protecting Your Data
News
Blog
Get Started
Why We Care
The Team
For Rare Disease Clinicians
FAQs
Protecting Your Data
News
Blog
Get Started
Steven Ringel 5/21/26 Steven Ringel 5/21/26

ASGCT 2026 Recap: How Personalized Gene Therapies Are Becoming Real for Rare Disease Families

Read More
Steven Ringel 5/5/26 Steven Ringel 5/5/26

How AI Can Cut the Cost of Personalized Gene Therapy

Read More
Steven Ringel 4/21/26 Steven Ringel 4/21/26

Who Owns the Cure? The Case for Patient Control in Rare Disease Drug Development

Read More
Steven Ringel 4/12/26 Steven Ringel 4/12/26

N-of-1 Therapy Explained: What are the steps and timelines?

Read More
Steven Ringel 4/12/26 Steven Ringel 4/12/26

The New York Times Wrote About Rare Disease Gene Therapy. Here Is What They Left Out

Read More
Steven Ringel 4/12/26 Steven Ringel 4/12/26

Patient-Derived Cells: The Essential Foundation for Personalized Drug Development.

Read More
Steven Ringel 4/12/26 Steven Ringel 4/12/26

Landscape Review: The State of Gene Therapy and ASO Development

Read More
Steven Ringel 4/12/26 Steven Ringel 4/12/26

Gene Replacement vs. Gene Editing: Are they the same thing?

Read More

Guiding rare disease patients and families toward experimental treatments with clarity, compassion, and expert support.

Our Story

The Team

For Providers

FAQs

Contact Us

©Nome 2025. All rights reserved.

Privacy Policy | Terms of Service